236 related articles for article (PubMed ID: 34565341)
1. The effect of preventative cardiovascular therapies on coronary artery disease in people with and without type 2 diabetes: a propensity-matched score study.
Kiburg KV; MacIsaac AI; McCluskey GE; Sundararajan V; MacIsaac RJ
BMC Cardiovasc Disord; 2021 Sep; 21(1):463. PubMed ID: 34565341
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Subclinical Coronary Artery Disease in Atrial Fibrillation Patients Identified by Coronary Computed Tomography Angiography.
Nous FMA; Budde RPJ; van Dijkman ED; Musters PJ; Nieman K; Galema TW
Am J Cardiol; 2020 Jul; 126():16-22. PubMed ID: 32345472
[TBL] [Abstract][Full Text] [Related]
3. Impact of active smoking on the immature platelet fraction and its relationship with the extent of coronary artery disease.
Nardin M; Verdoia M; Negro F; Rolla R; Tonon F; De Luca G
Eur J Clin Invest; 2020 Feb; 50(2):e13181. PubMed ID: 31659742
[TBL] [Abstract][Full Text] [Related]
4. Cardiac Medication Use in Patients with Acute Myocardial Infarction and Nonobstructive Coronary Artery Disease.
Adatia F; Galway S; Grubisic M; Lee M; Daniele P; Humphries KH; Sedlak TL
J Womens Health (Larchmt); 2017 Nov; 26(11):1185-1192. PubMed ID: 28384014
[TBL] [Abstract][Full Text] [Related]
5. Sex Differences in Cardiac Medication Use Post-Catheterization in Patients Undergoing Coronary Angiography for Stable Angina with Nonobstructive Coronary Artery Disease.
Galway S; Adatia F; Grubisic M; Lee M; Daniele P; Humphries KH; Sedlak TL
J Womens Health (Larchmt); 2017 Sep; 26(9):976-983. PubMed ID: 28384013
[TBL] [Abstract][Full Text] [Related]
6. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.
Anselmino M; Malmberg K; Ohrvik J; Rydén L;
Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):216-23. PubMed ID: 18391651
[TBL] [Abstract][Full Text] [Related]
7. Changes in preventive medical therapies and CV risk factors after CT angiography.
Cheezum MK; Hulten EA; Smith RM; Taylor AJ; Kircher J; Surry L; York M; Villines TC
JACC Cardiovasc Imaging; 2013 May; 6(5):574-81. PubMed ID: 23582355
[TBL] [Abstract][Full Text] [Related]
8. Glycaemic control and cardiovascular risk factor management in patients with diabetes with and without coronary artery disease: insights from the diabetes mellitus status in Canada survey.
Grenier J; Leiter LA; Langer A; Goldin L; Teoh H; Connelly KA; Cheng AYY; Tan MK; Fitchett D; McGuire DK; Goodman SG; Yan AT
Eur Heart J Qual Care Clin Outcomes; 2016 Oct; 2(4):277-284. PubMed ID: 29474711
[TBL] [Abstract][Full Text] [Related]
9. The impact of in-hospital cardiac rehabilitation program on medication adherence and clinical outcomes in patients with acute myocardial infarction in the Lazio region of Italy.
Soldati S; Di Martino M; Rosa AC; Fusco D; Davoli M; Mureddu GF
BMC Cardiovasc Disord; 2021 Sep; 21(1):466. PubMed ID: 34565326
[TBL] [Abstract][Full Text] [Related]
10. Coronary artery disease detected by coronary computed tomographic angiography is associated with intensification of preventive medical therapy and lower low-density lipoprotein cholesterol.
Hulten E; Bittencourt MS; Singh A; O'Leary D; Christman MP; Osmani W; Abbara S; Steigner ML; Truong QA; Nasir K; Rybicki FF; Klein J; Hainer J; Brady TJ; Hoffmann U; Ghoshhajra BB; Hachamovitch R; Di Carli MF; Blankstein R
Circ Cardiovasc Imaging; 2014 Jul; 7(4):629-38. PubMed ID: 24906356
[TBL] [Abstract][Full Text] [Related]
11. Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI Registry.
Maddox TM; Ho PM; Roe M; Dai D; Tsai TT; Rumsfeld JS
Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):632-41. PubMed ID: 20923997
[TBL] [Abstract][Full Text] [Related]
12. Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology.
Gyberg V; De Bacquer D; De Backer G; Jennings C; Kotseva K; Mellbin L; Schnell O; Tuomilehto J; Wood D; Rydén L; Amouyel P; Bruthans J; Conde AC; Cifkova R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pająk A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D;
Cardiovasc Diabetol; 2015 Oct; 14():133. PubMed ID: 26427624
[TBL] [Abstract][Full Text] [Related]
13. Sex-related disparities in the incidence and outcomes of hemorrhagic stroke among type 2 diabetes patients: a propensity score matching analysis using the Spanish National Hospital Discharge Database for the period 2016-18.
Lopez-de-Andres A; Jimenez-Garcia R; Hernández-Barrera V; Jiménez-Trujillo I; de Miguel-Yanes JM; Carabantes-Alarcon D; de Miguel-Diez J; Lopez-Herranz M
Cardiovasc Diabetol; 2021 Jul; 20(1):138. PubMed ID: 34243780
[TBL] [Abstract][Full Text] [Related]
14. Does pharmacologic treatment in patients with established coronary artery disease and diabetes fulfil guideline recommended targets? A report from the EUROASPIRE III cross-sectional study.
Gyberg V; Kotseva K; Dallongeville J; Backer GD; Mellbin L; Rydén L; Wood D; Bacquer DD;
Eur J Prev Cardiol; 2015 Jun; 22(6):753-61. PubMed ID: 24691153
[TBL] [Abstract][Full Text] [Related]
15. Effect of Secondary Prevention Medication on the Prognosis in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease.
Abdu FA; Liu L; Mohammed AQ; Xu B; Yin G; Xu S; Xu Y; Che W
J Cardiovasc Pharmacol; 2020 Dec; 76(6):678-683. PubMed ID: 33284169
[TBL] [Abstract][Full Text] [Related]
16. Patients with acute coronary syndrome and nonobstructive coronary artery disease in the real world are markedly undertreated.
De Ferrari GM; Leonardi S; Baduena L; Chieffo E; Lesce A; Repetto A; Previtali M
J Cardiovasc Med (Hagerstown); 2011 Oct; 12(10):700-8. PubMed ID: 21738050
[TBL] [Abstract][Full Text] [Related]
17. Gender disparities in diabetes and coronary heart disease medication among patients with type 2 diabetes: results from the DIANA study.
Krämer HU; Raum E; Rüter G; Schöttker B; Rothenbacher D; Rosemann T; Szecsenyi J; Brenner H
Cardiovasc Diabetol; 2012 Jul; 11():88. PubMed ID: 22838970
[TBL] [Abstract][Full Text] [Related]
18. Utilization of Evidence-Based Secondary Prevention Medications at the Time of Discharge in Patients with Acute Coronary Syndrome (ACS) in Qatar.
El-Hajj MS; Saad A; Al-Suwaidi J; Al-Marridi WZ; Elkhalifa DH; Mohamed AA; Mahfoud ZR
Curr Vasc Pharmacol; 2016; 14(4):394-403. PubMed ID: 26916397
[TBL] [Abstract][Full Text] [Related]
19. Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis.
Brown LC; Johnson JA; Majumdar SR; Tsuyuki RT; McAlister FA
CMAJ; 2004 Nov; 171(10):1189-92. PubMed ID: 15534311
[TBL] [Abstract][Full Text] [Related]
20. Chronic polytherapy after myocardial infarction: the trade-off between hospital and community-based providers in determining adherence to medication.
Di Martino M; Alagna M; Lallo A; Gilmore KJ; Francesconi P; Profili F; Scondotto S; Fantaci G; Trifirò G; Isgrò V; Davoli M; Fusco D
BMC Cardiovasc Disord; 2021 Apr; 21(1):180. PubMed ID: 33853534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
